Mechanistically, TOP2A may activate the Wnt signaling pathway by interacting with the canonical ligand Wnt3a to stimulate β-catenin entry into the nucleus, thereby promoting NSCLC metastasis. Here, TOP2A is linked to non-small cell lung carcinoma.